Kathleen A. Rickard, Chief Medical Officer at Verona Pharma plc (VRNA), sold 237,424 shares at $2.56 ($606K) on 2023-02-01, disclosed to the SEC on 2023-02-03.
Open-market sale of $606k VRNA by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.56 | 89,960 | $230K | 38.0% |
| 2 | $2.56 | 89,960 | $230K | 38.0% |
| 3 | $2.53 | 28,752 | $73K | 12.0% |
| 4 | $2.53 | 28,752 | $73K | 12.0% |
| Total | $2.55 avg | 237,424 | $606K | 100% |
| Filing → |
| VRNA | SELL | 2025-05-05 | $881K | — | Filing → |
| VRNA | SELL | 2025-05-01 | $618K | — | Filing → |
| VRNA | SELL | 2025-03-13 | $1.3M | — | Filing → |